If the findings are replicated, measuring levels of interleukin 6 could help doctors decide which patients with depression would be best suited for treatment with ECT.
If replicated in larger studies, the findings could lead to new types of programs to improve mental agility in older adults by combining mental training with physical fitness.
“If the results ... are replicated in future studies, the methods we used could potentially give clinicians a new predictive tool,” said UCLA doctoral student Nicco Reggente.
The substance’s beneficial properties might be due to its ability to reduce inflammation, which has been linked to both Alzheimer’s disease and major depression, according to Dr. Gary Small.
The study shows that treatments tailored for different disabilities caused by MS could be more effective than treatments intended to target multiple different disabilities.
Protein-imaging method developed by new UCLA researcher overcomes challenges of current techniques, offering untold potential in the exploration of disease and treatment.
The study sheds light on the relationship of theta oscillations to human learning and exploration — and it could help inform future research on therapies for patients with memory disorders like Alzheimer’s disease.
A UCLA digital artist and neuroscientist collaborated to create a performance art installation in which participants explore unspoken, visual communication.
A new study is the first to reveal how sleep deprivation disrupts our brain cells’ ability to communicate with each other, which scientists believe leads to temporary mental lapses.
The grant “will allow UCLA to continue our decade-long preeminence in groundbreaking autism research,” said Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment.